Previous close | 1.6300 |
Open | 1.6300 |
Bid | 1.6500 |
Ask | 1.8000 |
Strike | 3.00 |
Expiry date | 2024-05-17 |
Day's range | 1.6300 - 1.6300 |
Contract range | N/A |
Volume | |
Open interest | 678 |
Marinus Pharmaceuticals (MRNS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Marinus Pharmaceuticals, Inc. ( NASDAQ:MRNS ) just released its latest first-quarter report and things are not looking...
Marinus Pharmaceuticals (MRNS) delivered earnings and revenue surprises of 0% and 10.81%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?